Previous Close | 1.0300 |
Open | 1.0366 |
Bid | 1.1000 x 200 |
Ask | 1.4100 x 200 |
Day's Range | 1.0366 - 1.2000 |
52 Week Range | 0.9250 - 49.0000 |
Volume | |
Avg. Volume | 214,390 |
Market Cap | 85.002M |
Beta (5Y Monthly) | N/A |
PE Ratio (TTM) | N/A |
EPS (TTM) | -0.1800 |
Earnings Date | N/A |
Forward Dividend & Yield | N/A (N/A) |
Ex-Dividend Date | N/A |
1y Target Est | N/A |
Citius Pharmaceuticals, Inc. ("Citius Pharma" or the "Company") (Nasdaq: CTXR), today announced that Chairman and CEO Leonard Mazur will present and host one-on-one investor meetings at the H.C. Wainwright & Co. 26th Annual Global Investment Conference taking place September 9–11, 2024, in New York City.